RESEARCHER PROFILE

Remco Nagel

← Back to Oncode Institute

R

Oncode Institute

Cancer-related Molecular PathwaysCancer-related molecular mechanisms researchMicroRNA in disease regulationFOXO transcription factor regulationCancer Mechanisms and Therapy

Remco Nagel works in Cancer-related Molecular Pathways, Cancer-related molecular mechanisms research, MicroRNA in disease regulation, FOXO transcription factor regulation, Cancer Mechanisms and Therapy. Recorded institutional associations include The Netherlands Cancer Institute, Oncode Institute.

122Publications
5,898Citations
21H-index

Inclusion identifies researchers whose recorded research contributions may inform their university’s understanding of its research community. It does not rank individual research quality or establish current employment.

Selected research works

Up to 100 highly cited works; DOI links open the original research. Counts reflect the collected record, not real-time citation totals.

  1. A Genetic Screen Implicates miRNA-372 and miRNA-373 As Oncogenes in Testicular Germ Cell Tumors

    2006 · 1,264 citations
  2. The microRNAs miR-373 and miR-520c promote tumour invasion and metastasis

    2008 · 975 citations
  3. Regulation of the p27Kip1 tumor suppressor by miR‐221 and miR‐222 promotes cancer cell proliferation

    2007 · 815 citations
  4. RNA-Binding Protein Dnd1 Inhibits MicroRNA Access to Target mRNA

    2007 · 732 citations
  5. Regulation of the Adenomatous Polyposis Coli Gene by the miR-135 Family in Colorectal Cancer

    2008 · 474 citations
  6. Origins, genetic landscape, and emerging therapies of small cell lung cancer

    2015 · 250 citations
  7. A Genetic Screen Implicates miRNA-372 and miRNA-373 as Oncogenes in Testicular Germ Cell Tumors

    2007 · 170 citations
  8. Anti-tumour immunity induces aberrant peptide presentation in melanoma

    2020 · 161 citations
  9. Drugging the addict: non‐oncogene addiction as a target for cancer therapy

    2016 · 151 citations
  10. Tryptophan depletion results in tryptophan-to-phenylalanine substitutants

    2022 · 148 citations
  11. The miRNA‐192/194 cluster regulates the Period gene family and the circadian clock

    2009 · 124 citations
  12. Treatment response of HPV-positive and HPV-negative head and neck squamous cell carcinoma cell lines

    2013 · 79 citations
  13. Functional Genetic Screens Identify Genes Essential for Tumor Cell Survival in Head and Neck and Lung Cancer

    2013 · 77 citations
  14. SLC1A3 contributes to L‐asparaginase resistance in solid tumors

    2019 · 71 citations
  15. Proteomic patterns associated with response to breast cancer neoadjuvant treatment

    2020 · 66 citations
  16. Diverse Ways to Control p27Kip1 Function: miRNAs Come into Play

    2007 · 62 citations
  17. Oncogene-dependent sloppiness in mRNA translation

    2021 · 61 citations
  18. Genome-wide siRNA Screen Identifies the Radiosensitizing Effect of Downregulation of MASTL and FOXM1 in NSCLC

    2015 · 37 citations
  19. Inhibition of the Replication Stress Response Is a Synthetic Vulnerability in SCLC That Acts Synergistically in Combination with Cisplatin

    2019 · 36 citations
  20. Proteome analysis of non-small cell lung cancer cell line secretomes and patient sputum reveals biofluid biomarker candidates for cisplatin response prediction

    2019 · 34 citations
  21. A comprehensive enhancer screen identifies TRAM2 as a key and novel mediator of YAP oncogenesis

    2021 · 24 citations
  22. Slippy-Sloppy translation: a tale of programmed and induced-ribosomal frameshifting

    2022 · 21 citations
  23. Boosting Antitumor Immunity with an Expanded Neoepitope Landscape

    2022 · 18 citations
  24. Adoptive T cell therapy targeting an inducible and broadly shared product of aberrant mRNA translation

    2025 · 17 citations
  25. CUEDC1 is a primary target of ERα essential for the growth of breast cancer cells

    2018 · 12 citations

← Return to the university profile